{"id":332486,"date":"2026-10-29T14:48:24","date_gmt":"2026-10-29T09:18:24","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=332486"},"modified":"2026-10-29T14:48:24","modified_gmt":"2026-10-29T09:18:24","slug":"largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Largecap Institutional Holding 20-40 Per Cent Stocks to Watch for Future Multibagger Potential: SBI, Sun Pharma, Titan and UltraTech Cement"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>SBI Rs 956.80. Sun Pharma Rs 1,757.50. Titan Rs 4,337.90. UltraTech Cement Rs 11,104. Market caps from Rs 3.21 lakh crore to Rs 8.69 lakh crore. Data as of 28 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">SBI, Sun Pharma, Titan and UltraTech Cement are the 4 picks in this institutional holding 20-40 per cent stocks watchlist, with market caps between Rs 3.21 lakh crore and Rs 8.69 lakh crore. SBI stands out for the lowest PE of the group at 9.69, while Sun Pharma offers the fastest profit growth, 35.75% a year since FY22. PE ratios run from 9.69 to 68.32, so compare each one with its industry PE before investing. All figures are as of 28 October 2026.<\/p>\n<\/p><\/div>\n<p>Institutional holding 20-40 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. SBI, Sun Pharma, Titan and UltraTech Cement meet that test, with market caps from Rs 3.21 lakh crore to Rs 8.69 lakh crore and SBI offering the lowest PE of the group at 9.69. Each of these companies has a combined FII and DII holding between 20 and 40 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a combined FII and DII holding between 20 and 40 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening institutional holding 20-40 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=institutional-holding-per-cent-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#What_Are_Institutional_Holding_20-40_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Institutional Holding 20-40 Per Cent Stocks and Why Do They Attract Multibagger Interest?\">What Are Institutional Holding 20-40 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Institutional_Holding_20-40_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_ROE_and_Price_to_Book\" title=\"Institutional Holding 20-40 Per Cent Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book\">Institutional Holding 20-40 Per Cent Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#SBI_2372_Profit_CAGR_Since_FY22\" title=\"SBI: 23.72% Profit CAGR Since FY22\">SBI: 23.72% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Sun_Pharma_3575_Profit_CAGR_Since_FY22\" title=\"Sun Pharma: 35.75% Profit CAGR Since FY22\">Sun Pharma: 35.75% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Titan_2326_Profit_CAGR_Since_FY22\" title=\"Titan: 23.26% Profit CAGR Since FY22\">Titan: 23.26% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#UltraTech_Cement_Profit_Compounding_at_336_a_Year\" title=\"UltraTech Cement: Profit Compounding at 3.36% a Year\">UltraTech Cement: Profit Compounding at 3.36% a Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Institutional_Holding_20-40_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Institutional Holding 20-40 Per Cent Stocks: Financial Comparison on Growth and Margins\">Institutional Holding 20-40 Per Cent Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_SBI_Sun_Pharma_Titan_and_UltraTech_Cement\" title=\"Institutional Holding in SBI, Sun Pharma, Titan and UltraTech Cement\">Institutional Holding in SBI, Sun Pharma, Titan and UltraTech Cement<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Institutional_Holding_20-40_Per_Cent_Stocks\" title=\"Risks to Weigh in Institutional Holding 20-40 Per Cent Stocks\">Risks to Weigh in Institutional Holding 20-40 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Institutional_Holding_20-40_Per_Cent_Stocks\" title=\"How to Choose Between Institutional Holding 20-40 Per Cent Stocks\">How to Choose Between Institutional Holding 20-40 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Institutional_Holding_20-40_Per_Cent_Stocks_to_Watch\" title=\"Frequently Asked Questions on Institutional Holding 20-40 Per Cent Stocks to Watch\">Frequently Asked Questions on Institutional Holding 20-40 Per Cent Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Which_are_the_best_institutional_holding_20-40_per_cent_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best institutional holding 20-40 per cent stocks to watch for multibagger potential?\">Which are the best institutional holding 20-40 per cent stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Is_Titan_a_good_stock_for_long-term_investors\" title=\"Is Titan a good stock for long-term investors?\">Is Titan a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Can_Sun_Pharma_become_a_multibagger_from_here\" title=\"Can Sun Pharma become a multibagger from here?\">Can Sun Pharma become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_SBI_Sun_Pharma_Titan_and_UltraTech_Cement\" title=\"What is the market cap of SBI, Sun Pharma, Titan and UltraTech Cement?\">What is the market cap of SBI, Sun Pharma, Titan and UltraTech Cement?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_institutional_holding_20-40_per_cent_stocks\" title=\"What are the risks of investing in institutional holding 20-40 per cent stocks?\">What are the risks of investing in institutional holding 20-40 per cent stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#Why_is_Titan_trading_at_a_PE_of_6832\" title=\"Why is Titan trading at a PE of 68.32?\">Why is Titan trading at a PE of 68.32?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/largecap-institutional-holding-20-40-per-cent-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_SBI_Sun_Pharma_Titan_and_UltraTech_Cement\" title=\"How much do institutions hold in SBI, Sun Pharma, Titan and UltraTech Cement?\">How much do institutions hold in SBI, Sun Pharma, Titan and UltraTech Cement?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Institutional_Holding_20-40_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Institutional Holding 20-40 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding 20-40 per cent stocks are shares of large companies in which foreign and domestic institutions together own between one fifth and two fifths of the company, a balanced level with room for funds to add more. The four here cover public sector banking, pharmaceuticals, jewellery and watches and cement.<\/p>\n<p>A moderate institutional stake shows that funds already trust the company while leaving space for fresh buying, and growth in profit gives them a reason to add. For institutional holding 20-40 per cent stocks, both FY26 and the latest quarter showed growth. Investors researching institutional holding 20-40 per cent stocks get a fuller picture by reading growth and valuation together. The table below lines up institutional holding 20-40 per cent stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use institutional holding 20-40 per cent stocks as a starting point for your own research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_20-40_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_ROE_and_Price_to_Book\"><\/span><strong>Institutional Holding 20-40 Per Cent Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 28 October 2026. SBI has the lowest PE of the group at 9.69, while Titan posts the highest return on equity at 32.31%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Price to Book<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sbin\/state-bank-of-india-share-price-today\">State Bank of India<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">956.80<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8,68,768<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.69<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.05<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.29%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1.48<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">877.05 to 1,234.70<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,757.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,22,307<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.85<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.05<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,583.70 to 2,046.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/titan\/titan-company-ltd-share-price-today\">Titan Company<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,337.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,93,523<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">68.32<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">46.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.31%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,506.50 to 5,186.70<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ultracemco\/ultratech-cement-ltd-share-price-today\">UltraTech Cement<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,104<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,20,895<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.44<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.41<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.66%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.19<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10,325.00 to 13,110.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"SBI_2372_Profit_CAGR_Since_FY22\"><\/span><strong>SBI: 23.72% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>State Bank of India is the country&#8217;s largest lender, with a branch network that reaches every part of India. It reported FY26 total income of Rs 7,12,643.53 crore, up 7.43% year on year, and net profit of Rs 85,168.47 crore, up 7.78%. Net profit has compounded at 23.72% a year since FY22, while total income has grown 15.03% a year.<\/p>\n<p>In the June 2026 quarter, total income rose 7.83% to Rs 1,80,061.86 crore and net profit grew 13.65% to Rs 24,579.04 crore. The share price has gained 92.86% over five years. Foreign investors raised their holding from 9.98% in July 2025 to 10.81% in June 2026. The stock trades at a PE of 9.69 against an industry PE of 12.05, below the sector average, with a return on equity of 14.29%. The dividend yield is 1.85%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_3575_Profit_CAGR_Since_FY22\"><\/span><strong>Sun Pharma: 35.75% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharmaceutical Industries is one of India&#8217;s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 34.85 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%. In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Titan_2326_Profit_CAGR_Since_FY22\"><\/span><strong>Titan: 23.26% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Titan Company runs the jewellery (Tanishq), watches (Titan), eyewear and fragrances businesses. It reported FY26 revenue of Rs 88,136 crore, up 44.62% year on year, and net profit of Rs 5,073 crore, up 52.02%. Net profit has compounded at 23.26% a year since FY22, while revenue has grown 32.00% a year. Operating margin was 10.06% in FY26.<\/p>\n<p>In the June 2026 quarter, revenue rose 29.31% to Rs 21,502 crore and net profit grew 62.88% to Rs 1,777 crore. The share price has gained 72.39% over five years and 22.47% over the past year. Domestic institutions raised their holding from 12.78% in June 2025 to 15.34% in June 2026. The stock trades at a PE of 68.32 against an industry PE of 46.75, with a return on equity of 32.31%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"UltraTech_Cement_Profit_Compounding_at_336_a_Year\"><\/span><strong>UltraTech Cement: Profit Compounding at 3.36% a Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>UltraTech Cement is the largest cement producer in India by capacity, with plants and grinding units across the country. It reported FY26 revenue of Rs 89,089.04 crore, up 16.15% year on year, and net profit of Rs 8,188.35 crore, up 35.58%. Revenue has compounded at 13.81% a year since FY22. Operating margin was 19.71% in FY26. The debt-to-equity ratio is 0.31.<\/p>\n<p>The stock trades at a PE of 37.44 against an industry PE of 29.41. The dividend yield is 2.20%. In the June 2026 quarter, revenue rose 15.49% to Rs 24,778.47 crore and net profit grew 17.24% to Rs 2,603.72 crore. Domestic institutions raised their holding from 16.65% in September 2025 to 20.86% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_20-40_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Institutional Holding 20-40 Per Cent Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these institutional holding 20-40 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Total Income (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Income Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Income CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">SBI<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7,12,643.53<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">85,168.47<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.43%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.03%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.72%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61,673.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,564.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.75%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Titan<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">88,136<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,073<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.00%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">UltraTech Cement<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">89,089.04<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8,188.35<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.81%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3.36%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these institutional holding 20-40 per cent stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_SBI_Sun_Pharma_Titan_and_UltraTech_Cement\"><\/span><strong>Institutional Holding in SBI, Sun Pharma, Titan and UltraTech Cement<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these institutional holding 20-40 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. SBI has the deepest institutional backing, with FII and DII together holding 37.45% as of June 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%), Titan (from 12.78% to 15.34%) and UltraTech Cement (from 16.65% to 20.86%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">SBI<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">55.47%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.81%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">26.64%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.08%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.27%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.70%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Titan<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.90%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.34%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">UltraTech Cement<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">58.48%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.86%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.97%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Institutional_Holding_20-40_Per_Cent_Stocks\"><\/span><strong>Risks to Weigh in Institutional Holding 20-40 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with institutional holding 20-40 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Titan trades at a PE of 68.32 against an industry PE of 46.75, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Institutional_Holding_20-40_Per_Cent_Stocks\"><\/span><strong>How to Choose Between Institutional Holding 20-40 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from institutional holding 20-40 per cent stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.<\/li>\n<li>Compare each PE with the industry PE (12.05 to 46.75) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track SBI, Sun Pharma, Titan and UltraTech Cement live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among institutional holding 20-40 per cent stocks, SBI stands out for the lowest PE of the group at 9.69, Sun Pharma for the fastest profit growth, 35.75% a year since FY22, Titan for the highest return on equity at 32.31% and UltraTech Cement for 16.15% revenue growth in FY26. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing institutional holding 20-40 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Institutional_Holding_20-40_Per_Cent_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Institutional Holding 20-40 Per Cent Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_institutional_holding_20-40_per_cent_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best institutional holding 20-40 per cent stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SBI, Sun Pharma, Titan and UltraTech Cement are the 4 names this list highlights, with market caps of Rs 8,68,768 crore, Rs 4,22,307 crore, Rs 3,93,523 crore and Rs 3,20,895 crore respectively. SBI is notable for the lowest PE of the group at 9.69. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22. Titan offers the highest return on equity at 32.31%. UltraTech Cement brings 16.15% revenue growth in FY26. These are watchlist names for institutional holding 20-40 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Titan_a_good_stock_for_long-term_investors\"><\/span><strong>Is Titan a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Titan has a return on equity of 32.31%, a PE of 68.32 against an industry PE of 46.75 and a market cap of Rs 3,93,523 crore. Net profit has compounded at 23.26% a year since FY22, and FY26 revenue rose 44.62% while June 2026 quarter net profit grew 62.88%. Long-term returns in institutional holding 20-40 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Sun_Pharma_become_a_multibagger_from_here\"><\/span><strong>Can Sun Pharma become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in institutional holding 20-40 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.85 against an industry PE of 36.42, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_SBI_Sun_Pharma_Titan_and_UltraTech_Cement\"><\/span><strong>What is the market cap of SBI, Sun Pharma, Titan and UltraTech Cement?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 28 October 2026, SBI has a market cap of Rs 8,68,768 crore, Sun Pharma has a market cap of Rs 4,22,307 crore, Titan has a market cap of Rs 3,93,523 crore and UltraTech Cement has a market cap of Rs 3,20,895 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on institutional holding 20-40 per cent stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_institutional_holding_20-40_per_cent_stocks\"><\/span><strong>What are the risks of investing in institutional holding 20-40 per cent stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Titan trades at a PE of 68.32 against an industry PE of 46.75, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Titan_trading_at_a_PE_of_6832\"><\/span><strong>Why is Titan trading at a PE of 68.32?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Titan&#8217;s PE of 68.32 compares with an industry PE of 46.75. The market is paying a premium for a return on equity of 32.31%, profit growth of 23.26% a year since FY22 and latest-quarter profit growth of 62.88%, which also means the stock is more sensitive if growth slows. Investors in institutional holding 20-40 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_SBI_Sun_Pharma_Titan_and_UltraTech_Cement\"><\/span><strong>How much do institutions hold in SBI, Sun Pharma, Titan and UltraTech Cement?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 37.45% of SBI (10.81% and 26.64%), 36.63% of Sun Pharma (14.36% and 22.27%), 30.72% of Titan (15.38% and 15.34%) and 33.55% of UltraTech Cement (12.69% and 20.86%). Rising institutional holding is a useful signal in institutional holding 20-40 per cent stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best institutional holding 20-40 per cent stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SBI, Sun Pharma, Titan and UltraTech Cement are the 4 names this list highlights, with market caps of Rs 8,68,768 crore, Rs 4,22,307 crore, Rs 3,93,523 crore and Rs 3,20,895 crore respectively. SBI is notable for the lowest PE of the group at 9.69. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22. Titan offers the highest return on equity at 32.31%. UltraTech Cement brings 16.15% revenue growth in FY26. These are watchlist names for institutional holding 20-40 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Titan a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Titan has a return on equity of 32.31%, a PE of 68.32 against an industry PE of 46.75 and a market cap of Rs 3,93,523 crore. Net profit has compounded at 23.26% a year since FY22, and FY26 revenue rose 44.62% while June 2026 quarter net profit grew 62.88%. Long-term returns in institutional holding 20-40 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Sun Pharma become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in institutional holding 20-40 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.85 against an industry PE of 36.42, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of SBI, Sun Pharma, Titan and UltraTech Cement?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 28 October 2026, SBI has a market cap of Rs 8,68,768 crore, Sun Pharma has a market cap of Rs 4,22,307 crore, Titan has a market cap of Rs 3,93,523 crore and UltraTech Cement has a market cap of Rs 3,20,895 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on institutional holding 20-40 per cent stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in institutional holding 20-40 per cent stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Titan trades at a PE of 68.32 against an industry PE of 46.75, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Titan trading at a PE of 68.32?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Titan's PE of 68.32 compares with an industry PE of 46.75. The market is paying a premium for a return on equity of 32.31%, profit growth of 23.26% a year since FY22 and latest-quarter profit growth of 62.88%, which also means the stock is more sensitive if growth slows. Investors in institutional holding 20-40 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in SBI, Sun Pharma, Titan and UltraTech Cement?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 37.45% of SBI (10.81% and 26.64%), 36.63% of Sun Pharma (14.36% and 22.27%), 30.72% of Titan (15.38% and 15.34%) and 33.55% of UltraTech Cement (12.69% and 20.86%). Rising institutional holding is a useful signal in institutional holding 20-40 per cent stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 largecap institutional holding 20-40 per cent stocks compared on market cap, PE, ROE, growth and institutional holding: SBI, Sun Pharma, Titan and UltraTech Cement.<\/p>\n","protected":false},"author":33,"featured_media":332485,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[18213,18212],"class_list":["post-332486","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-institutional-holding-20-40-per-cent-sector","tag-institutional-holding-20-40-per-cent-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["332485"],"rank_math_title":["Institutional Holding 20-40 Per Cent Stocks 2026: SBI, Sun Pharma"],"rank_math_description":["Institutional holding 20-40 per cent stocks to watch for multibagger potential: SBI, Sun Pharma, Titan and UltraTech Cement. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["institutional holding 20-40 per cent stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-largecap-institutional-holding-20-40-per-cent-stocks-to-watch-for-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=332486"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332486\/revisions"}],"predecessor-version":[{"id":332487,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332486\/revisions\/332487"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/332485"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=332486"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=332486"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=332486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}